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Abstract
Objective: To identify, on the basis of past performance, those hospitals that demonstrate good outcomes in sufficient
numbers to make it likely that they will provide adequate quality of care in the future, using a combined measure of volume
and outcome (CM-V&O). To compare this CM-V&O with measures using outcome-only (O-O) or volume-only (V-O), and verify
2010-quality of care assessment on 2011 data.
Design: Secondary analysis of clinical audit data.
Setting: The Dutch Surgical Colorectal Audit database of 2010 and 2011, the Netherlands.
Participants: 8911 patients (test population, treated in 2010) and 9212 patients (verification population, treated in 2011)
who underwent a resection of primary colorectal cancer in 89 Dutch hospitals.
Main Outcome Measures: Outcome was measured by Observed/Expected (O/E) postoperative mortality and morbidity. CM-
V&O states 2 criteria; 1) outcome is not significantly worse than average, and 2) outcome is significantly better than
substandard, with ‘substandard care’ being defined as an unacceptably high O/E threshold for mortality and/or morbidity
(which we set at 2 and 1.5 respectively).
Results: Average mortality and morbidity in 2010 were 4.1 and 24.3% respectively. 84 (94%) hospitals performed ‘not worse
than average’ for mortality, but only 21 (24%) of those were able to prove they were also ‘better than substandard’ (O/E,2).
For morbidity, 42 hospitals (47%) met the CM-V&O. Morbidity in 2011 was significantly lower in these hospitals (19.8 vs.
22.8% p,0.01). No relationship was found between hospitals’ 2010 performance on O-O en V-O, and the quality of their
care in 2011.
Conclusion: CM-V&O for morbidity can be used to identify hospitals that provide adequate quality and is associated with
better outcomes in the subsequent year.
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Introduction
Increasingly, society demands that health care providers
demonstrate that the quality of the care they provide is adequate.
However, it is not clear how quality should be measured and
judged. Quality of health care has been defined as ‘‘the degree to
which health services for individuals and populations increase the
likelihood of desired health outcomes and are consistent with
current professional knowledge’’[1]. Patient safety (the prevention
of unintended harm) is an essential element of quality of care.
Assessing quality, in particular patient safety, on the basis of
outcome, i.e. the occurrence of adverse outcomes, has proven
unreliable. The incidence of adverse outcomes is usually low, so
the absence of adverse outcomes in a small series of patients is
likely even if care were substandard. In the same way, when
procedural volume is low, even an adverse event rate of 3 or 5
times average may still be ‘not significantly worse than average’[2].
For this reason, and because higher procedural volume is
associated with better outcome, the emphasis in quality assessment
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has shifted from outcome to volume. Procedural volume has thus
become a surrogate measure for quality [3,4]. Accordingly,
political focus in the Netherlands now aims at concentrating care
into high volume centres. Recently, the Association of Surgeons of
the Netherlands (ASN) has set the minimal annual procedural
volume for colorectal resections at 50 procedures per hospital per
year. However, any volume criterion is arbitrary and ignores the
fact that lower volumes (e.g. 45 per year) do not exclude high
quality, just as high volumes do not rule out substandard care.
Therefore assessing quality on the basis of volume only, ignoring
outcome, is as inadequate as assessing it by outcome only, ignoring
volume. We therefore propose a quality measure that combines
volume and outcome, and corrects for case-mix variation to
provide statistical evidence that care is both ‘not significantly worse
than average’ as well as ‘significantly better than substandard’. A
hospital that meets both criteria deserves public confidence that its
quality of care is adequate.
The aim of the present study is to elucidate and test the
proposed method and compare hospitals by three measures to
define adequate quality: 1) outcome only (O-O), 2) volume only
(V-O), and 3) a combined measure of volume and outcome (CM-
V&O). We aim to demonstrate that the CM-V&O not only has a
better theoretical basis, but that it also identifies hospitals with
better outcome in the subsequent year.
Patients and Methods
Patients
We used the database of the Dutch Surgical Colorectal Audit
(DSCA, www.DSCA.nl), which has been created in accordance
with principles pioneered earlier in the UK and the Scandinavian
countries[5]. Details on procedures, data registration and data
validity have been described in a recent paper[6]. For the present
study (for which no ethical approval was required) we used data
from patients treated in 2010 as study database, and validated our
measures on patients treated in 2011. The study population
consisted of 8,911 patients who underwent a resection for a
primary colorectal cancer during 2010 in one of 89 participating
Dutch hospitals. The verification population consisted of 9,212
patients, treated in the same 89 hospitals in 2011. These databases
include 93% of all patients treated, and 96% of Dutch hospitals.
An observation period of 1 year was chosen, as this is the time-
span commonly used for benchmarking in quality assurance. Data
included 15 case-mix factors (age, gender, Body Mass Index
(BMI), preoperative ASA-score, Charlson comorbidity-score[7],
history of previous abdominal surgery, Tumour Node Metastasis
(TNM) stage, preoperative radiation therapy, preoperative tumour
complications (perforation, obstruction or other), multiple syn-
chronous tumors, urgency and type of procedure (right, left/
transverse, sigmoid, low anterior or abdomino-perineal resection,
and/or extended resection for locally advanced tumour or
metastases), as well as outcome. Outcome was assessed by
postoperative mortality, occurring either during hospital admission
or within 30 days after resection, and/or by serious morbidity, i.e.
leading to an intervention (operative or percutaneous) or to
prolonged hospital stay (14 days or more).
Analyses
Risk-adjusted Observed/Expected (O/E) outcome ratio was
used as the basic measure of hospital specific quality of care.[8,9]
Observed outcome is the number of adverse outcomes (mortality
or morbidity) that occur in a particular hospital in one year, while
expected outcome is the sum of all patients’ estimated probabilities
for these outcomes in that same hospital that year. These
probability estimates for patients’ mortality and morbidity were
derived from a backwards-stepwise multivariate logistic regression
model, fitted on the data of that year, of all hospitals. For each of
the 89 hospitals studied, O/E outcome ratios (including the exact
Poisson 95% confidence intervals) were calculated both for
mortality and morbidity, and for 2010 and 2011 separately[10].
For a hospital with average performance, the observed outcome
will equal the expected outcome, resulting in an O/E outcome
ratio of 1. Hospitals that perform better than average have an
O/E outcome ratio lower than 1, while this ratio is higher than 1
in hospitals with poorer than average performance.
We compared the 89 hospitals according to 3 different quality
measures:
A. Outcome-only, this (historical) measure assesses whether
patient outcomes are not worse than a predefined ‘threshold
for substandard care’. For the present study, the base-case
threshold for substandard care was defined as an O/E
outcome ratio of 2 for mortality, and of 1.5 for morbidity (and
was varied in sensitivity-analyses to 1.5 and 3). Note that this
approach ignores the existence and size of a confidence
interval (which depends partly on volume) around the point
estimate of the O/E ratio.
B. Volume-only, a more recently proposed measure, assesses
whether the volume of procedures (irrespective of outcome) is
at least as high as the (arbitrary) threshold of 50 colorectal
resections per year set by the Association of Surgeons of the
Netherlands (including those for benign diseases). As we did
not have any information on benign procedures, for the
present study the volume threshold was defined as at least 50
colorectal cancer resections in the year 2010.
C. A combined measure of volume and outcome, assesses
not only whether outcome is adequate, but in addition
whether patient volume is sufficiently high to narrow the
uncertainty around the observed outcome to an acceptable
range. In the CM-V&O, the minimal volume is therefore not
a normative threshold, but a statistical condition for reliable
assessment of hospital outcome. To pass this measure, a
hospital should meet two criteria:
1) its O/E outcome ratio must be ‘not significantly worse
than average’, i.e. the lower limit of the 95% confidence
interval (CI95min for short) of its O/E outcome ratio
should be no higher than 1, and
2) its O/E outcome ratio must be ‘significantly better than
substandard’, i.e. the upper limit of the 95% confidence
interval (CI95max for short) of its O/E outcome ratio
should be lower than the predefined threshold for
substandard care (see A).
Conceptually, these two criteria mean ‘no proof of care being
bad’ and ‘sufficient proof of care being OK’ respectively, with the
burden of proof lying in particular with the hospital for the second
criterion.
Verification
A good measure is not only discriminative, meaning that it will
identify the adequately performing hospitals and detect the
hospitals with insufficient quality, but also reliable, meaning that
it will not only do so for the year measured, but also the following
year. To validate the reliability of the CM-V&O, we compared
2011 outcomes between hospitals meeting or failing different
measures in 2010, to see if hospitals’ quality of care in 2011 was
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predicted by their performance on the measures O-O, V-O and
CM-V&O in 2011. To translate the O/E outcomes to clinical
outcomes, we also calculated the risk-adjusted outcomes (O/E
outcome multiplied by the national average outcome). Also, we
also performed the reversed analysis: we investigated if the
different measures also detected hospitals with insufficient quality
the following year by calculating how many of the hospitals that
were ‘significantly worse than average’ in 2011, were detected by
the different quality measures as delivering substandard care in
2010 (i.e. NOT meeting the different measures).
All statistics were performed in PASW Statistics for Mac, Rel
18.0.2009. Chicago: SPSS inc. and Microsoft Excel.
Results
Patients
The study population (2010) consisted of 8,911 patients treated
in 89 hospitals, with an average procedural volume of 100 patients
per year (range 14–241). The population average mortality and
morbidity rates were 4.1% and 24.3% respectively. Seven out of
15 case-mix factors (age, gender, ASA, Carlson score, type of
procedure, preoperative radiation therapy and urgency) predicted
mortality with good accuracy. Morbidity was predicted by 12
factors (all except BMI, TNM-stage and synchronous metasta-
sectomy). The model predicting mortality, and that predicting
morbidity, had similar test-characteristics (C-statistics 0.80 CI95
0.78–0,82 and 0.75 CI95 0.72–0.78 respectively). The two models
were used to calculate expected mortality and expected morbidity,
and O/E mortality and morbidity ratios for each hospital. The
average hospital O/E mortality ratio was 1.04 (CI95 0.90–1.19),
the average O/E morbidity ratio 0.97 (CI95 0.90–1.04). (Figure 1
and 2).
The verification population (2011) consisted of 9,212 patients,
treated in the same 89 hospitals. Average morbidity and mortality
rates decreased significantly in 2011, as compared to 2010: 3.7%
(p,0.01) and 21.5% (p,0.01) respectively, as described previous-
ly.[11] Table 1 shows patient, tumour and treatment character-
istics and outcome in the DSCA in the study population of 2010
and the verification population of 2011.
Three measures for adequate quality in 2010
UsingO-O as the measure for adequate quality, 82 (92%) of the
hospitals met the O/E ratio #2 for mortality, and 84 (94%; see
table 2) met the O/E ratio #1.5 for morbidity.
With respect to V-O, 9 hospitals (10%) performed less than 50
resections for primary colorectal cancer, while the remaining 80
hospitals (90%) met the volume threshold of 50 or more (table 2).
CM-V&O states, as explained before, 2 criteria:
- Criterion 1): being ‘not significantly worse than average’
For mortality, 84 hospitals (94%) had an O/E mortality ratio
which was ‘not significantly worse than average’, CI95min ,=1
(table 2). Three of these hospitals even performed significantly
better than average (i.e. even CI95max ,1). The remaining 5
hospitals had an O/E mortality ratio worse than average (i.e.
CI95min .1). For morbidity, 81 (90%) hospitals had an O/E
morbidity ratio that was ‘not significantly worse than average’
(table 2), of which 11 hospitals were even significantly better than
average. In the remaining 8 hospitals, O/E morbidity ratio was
significantly worse than average. One hospital performed signif-
icantly worse than average on both mortality and morbidity, and
one hospital was significantly better than average on both outcome
measures. None of the hospitals that were significantly better than
average on one outcome measure were ‘significantly worse than
average’ on the other.
- Criterion 2): being ‘significantly better than substandard’
At an O/E outcome ratio of 2 as the threshold for substandard
care, 21 hospitals (24%) were ‘significantly better than substan-
dard’ (i.e. CI95max ,2, see table 2). All of these hospitals were
also ‘not significantly worse than average’ and thus met both
criteria of CM-V&O. For morbidity, 77 hospitals were ‘signifi-
cantly better than substandard’ (CI95max ,2), of which 74 met
both criteria. All hospitals that met both criteria for mortality also
did so for morbidity.
Using different thresholds for ‘substandard care’
If we had used a stricter threshold for substandard care, such as
an O/E outcome ratio of 1.5, the number of hospitals meeting
CM-V&O would have dropped to just 13 for mortality, and to 42
for morbidity (table 2). Using a more lenient threshold for
substandard care of 3, 56 hospitals would have met CM-V&O for
mortality, and 81 for morbidity (table 2).
Comparing the three quality measures
Table 3 shows that 61 hospitals met the O-O measure for
mortality, but had insufficient procedural volume to assess hospital
postoperative outcome reliably. As a result of this their CI95max
ranged up to 7 times the expected mortality. For morbidity, 37
hospitals met the O-O measure, but not the CM-V&O. Similarly,
61 hospitals met the V-O measure for mortality but outcomes
were inadequate to meet the CM-V&O (for morbidity: 39
hospitals). Among these 61 hospitals there were also the 5
hospitals with an O/E mortality ratio significantly worse than
average (for morbidity: 8 hospitals). On the other hand, there were
also 2 hospitals that did meet the CM-V&O, but not the V-O
measure (for morbidity: 6 hospitals).
Verification
Hospitals meeting the CM-V&O for mortality in 2010 had a
lower risk-adjusted mortality, than hospitals that did not meet the
CM-V&O in 2010, but the difference was not statistically
significant (3.3 vs 3.9%, n.s.) [Table 4]. Hospitals that met the
V-O measure in 2010 had a higher, rather than lower, risk-
adjusted mortality in 2011. The CM-V&O detected 2 of 3
hospitals which performed significantly worse than average in
2011 (these hospitals did not meet the CM-V&O in 2010), while
none of the other measures detected any of the significantly worse
than average hospitals in 2011 (data not shown). For morbidity,
hospitals meeting the CM-V&O in 2010 had a significantly lower
risk-adjusted morbidity in 2011 (19.8 vs 22.8%, p,0.05), [Table 4]
while this effect was not found for the O-O or V-O measure. The
Figure 1. Observed/Expected (O/E) mortality ratio of all hospitals in the Dutch Surgical Colorectal Audit in 2010 and 2011. Measure
of ‘Outcome only’: requires that a hospital’s O/E ratio, regardless of its confidence interval, is below or equal to 2 (red fat printed line), met the
‘outcome only’ criterion. Measure of ‘Volume only’: requires that a hospital meets the ‘volume only’ criterion of .50 procedures per year (red squares)
Combined measure of ‘volume and outcome (CM-V&O)’: the lower limit of the confidence interval around the hospitals O/E ratio is below or equal to 1,
i.e. that the hospital is not significantly worse than average. In addition CM-V&O requires that the higher limit of the confidence interval is below 2 (fat
printed red line), i.e. that the hospital is significantly better than substandard.
doi:10.1371/journal.pone.0088737.g001
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Figure 2. Observed/Expected (O/E) morbidity ratio of all hospitals in the Dutch Surgical Colorectal Audit in 2010 and 2011. Measure
of ‘Outcome only’: requires that a hospital’s O/E ratio, regardless of its confidence interval, is below or equal to 1.5 (red fat printed line), met the
‘outcome only’ criterion. Measure of ‘Volume only’: requires that a hospital meets the ‘volume only’ criterion of .50 procedures per year (red squares)
Combined measure of ‘volume and outcome (CM-V&O)’: requires that the lower limit of the confidence interval around the hospitals O/E ratio is below
or equal to 1, i.e. that the hospital is not significantly worse than average. In addition CM-V&O requires that the higher limit of the confidence interval
is below 1.5 (fat printed red line), i.e. that the hospital is significantly better than substandard.
doi:10.1371/journal.pone.0088737.g002
Table 1. Patient, tumour and treatment characteristics and outcome in the DSCA 2010 and 2011.
Case-mix factors 2010 2011
N (%) N (%)
Age (years) ,70 4006 (45) 4222 (46)
70–79 2924 (33) 3038 (33)
80+ 1975 (22) 1935 (21)
Gender Male 4914 (55) 5065 (55)
Previous abdominal surgery Yes 2925 (33) 3087 (34)
Missing 132 (1.5) 117 (1.3)
ASA III+ 2094 (24) 2156 (23)
Missing 82 (1) 60 (1)
Charlson 2+ 969 (11) 1054 (11)
BMI ,25 3248 (36) 3678 (40)
25–30 2769 (31) 3468 (38)
.30 1169 (13) 1362 (15)
Missing 1725 (19) 703 (8)
TNM stage I and II 4884 (55) 4900 (53)
III 2769 (31) 2896 (31)
IV 1053 (12) 1053 (11)
X 205 (2) 363 (4)
Synchronous tumours Yes 246 (3) 311 (3)
Neoadjuvant therapy Radiotherapy 565 gy 1257 (14) 1268 (14)
Radiotherapy .60 gy 173 (2) 256 (3)
Chemo-radiation 727 (8) 789 (9)
Preoperative complication Feacal peritonitis 153 (2) 117 (1)
Obstruction 798 (9) 103 (11)
Other
Urgency Urgent 794 (9) 679 (7)
Acute 487 (6) 648 (7)
Procedure Right hemi-colectomy 3142 (35) 3013 (33)
Left hemi-colectomy* 830 (9) 892 (10)
Sigmoid/LAR 3783 (43) 4107 (45)
Abdomino-perineal resection 732 (8) 812 (9)
Other ‘ 442 (5) 388 (4)
Additional resection Locally advanced tumour 840 (9) 875 (10)
Metastasis 250 (3) 351 (4)
Mortality 365 (4.1) 343 (3.7)
Morbidity 2167 (24.3) 1982 (21.5)
ASA= American Society of Anaesthesiologists classification BMI = Body Mass Index, TNM= Tumour Node Metastasis classification system, gy = gray LAR= Low anterior
resection, * = including transverse colectomies, ‘ = including subtotal or proctocolectectomy.
doi:10.1371/journal.pone.0088737.t001
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CM-V&O detected 3 out of 4 hospitals that were significantly
worse than average in 2011, while the O-O measure detected only
one, and the V-O measure detected none of the significantly worse
than average hospitals in 2011 (data not shown).
Discussion
In the present study we propose and test a (risk-adjusted)
combined measure of volume and outcome to assess the quality of
care provided by hospitals. Hospitals that meet this quality
measure have not only demonstrably good health care outcomes,
but had sufficient annual numbers to demonstrate that their results
are not just a ‘lucky streak’, but a manifestation of consistently
good underlying quality of care. We demonstrated in the
verification population that hospitals meeting the CM-V&O for
morbidity had a significantly lower morbidity in the following
year. A similar trend was found for mortality; however this did not
reach statistical significance. Both the ‘volume only’ and ‘outcome
only’ measure did not identify the hospitals with better outcomes
the following year. Also, the CM-V&O performed better in
detecting hospitals that performed significantly worse than average
the next year.
The advantage of our study is that all analyses were performed
on large, reliable databases, containing almost nine thousand
patients per year from 89 hospitals. However, this also illustrates
that such calculations can only be performed if outcome
registration is excellent and relevant case-mix factors are included.
Fortunately, increasing awareness of the need for quality assurance
has led to an increasing dedication to reliable outcome registration
by means of National Clinical Audits. In the Netherlands, the first
Clinical Audit, the DSCA was initiated in 2009. Although
participation, completeness and validity were overwhelmingly
good after only one year of registration, the availability of weekly
online feedback data on hospital performances was relatively new
in the two years described in this study. In three years after the
introduction of clinical auditing, a significant improvement in
various process and outcome measures was observed, while
variation in hospital performances decreased. [11] These im-
provements may have interfered with the results of our study as
hospitals with substandard outcomes may have felt a greater
incentive for improvement of these outcomes, reducing the
Table 2. Number of hospitals meeting the measure of ‘outcome-only’ (better than substandard), of ‘volume-only’ (50 procedures
or more), or the combined measure of volume and outcome’ in 2010, using different thresholds for ‘substandard care’.
Quality measure Outcome only Volume only Combined measure of volume and outcome
Outcome
measure
Threshold for
substandard care
O/E ,=
substandard (%) N .=50 (%)
Not worse than
average:
CI95min , =1 (%)
Better than substandard:
CI95max , threshold (%) Both (%)
O/E,1.5 71 (80) 13 (15) 13 (15)
Mortality O/E,2 82 (92) 80 (90) 84 (94) 21 (24) 21 (24)
O/E,3 87 (98) 59 (66) 56 (63)
O/E,1.5 84 (94) 47 (53) 42 (47)
Morbidity O/E,2 89 (100) 80 (90) 81 (90) 77 (87) 74 (83)
O/E,3 89 (100) 89 (100) 81 (90)
N= number of patients.
O/E = Observed/Expected outcome ratio.
CI95min = Lower limit of 95% confidence interval around the O/E ratio.
CI95max = Upper limit of 95% confidence interval around the O/E ratio.
doi:10.1371/journal.pone.0088737.t002
Table 3. Comparing the number of hospitals meeting (or failing) the 3 different measures.
Quality measures met in 2010
Combined measure of volume and
outcome 2010*)
yes No
outcome only* O/E =,2 21 61
Mortality O/E.2 0 7
volume only N=.50 19 61
N,50 2 7
outcome only* O/E =,1.5 47 37
Morbidity O/E.1.5 0 5
volume only N=.50 41 39
N,50 6 3
O/E = Observed/Expected outcome ratio.
N = Hospital procedural volume.
*) using O/E ratio of .2 as the threshold for substandard care for mortality, and O/E ratio of .1.5 as the threshold for substandard care for morbidity.
doi:10.1371/journal.pone.0088737.t003
Combining Volume and Outcome to Assess Care
PLOS ONE | www.plosone.org 7 February 2014 | Volume 9 | Issue 2 | e88737
possible differences in outcome in 2011 between hospitals that did
and did not meet the different measures. Possibly, when this
selective quality improvement would not have taken place,
hospitals meeting the CM-V&O in 2010 would also have had a
lower risk adjusted mortality rate in 2011.
The ultimate measure for hospital performances on outcomes of
care would be discriminative and reliable, but also understandable for
all stakeholders. Although previous studies have found that a high
procedural volume for colorectal cancer is associated with better
outcome,[12] we found that the recently implemented minimal
volume chosen by the ASN (the ‘volume only’ measure) was not
discriminative, as it excluded hospitals with reliable and good
outcomes, and included hospitals with significantly worse than
average outcomes. We found that the measure was not reliable, as
hospitals with insufficient volume according to the ASN, although
few, did not perform worse than the hospitals with sufficient
numbers in 2011, but that their outcomes, although not
significant, were even better. Possibly, a cut-off point of 50
procedures is too low to identify high-quality hospitals. However,
our results are in line with recent evidence that suggests that
centralization only results in an improvement of outcome if
patients are referred to hospitals with a better outcome: outcome-
based referral[13–16]. On the other hand, we have also shown
that selecting hospitals based on ‘outcome only’, was also not
reliable, as it did not detect hospitals performing significantly worse
than average in 2011. Therefore, we propose to judge hospitals
using the CM-V&O. This measure identified the hospitals with
better outcomes the following year, and detected most of the
hospitals performing significantly worse than average the following
year, and was therewith most discriminative and reliable.
Moreover, this simple measure is also understandable for all
stakeholders. It may be argued that the CM-V&O, is too strict for
the Dutch hospitals, as only 24% of all hospitals met the measure.
By varying the ‘level of substandard care’ to for example an O/E
mortality of 3 (e.g. 3 times higher mortality rate than expected
based on the hospitals’ case-mix) the CM-V&O may be adjusted
so that more hospitals meet the measure. However, as the number
of hospitals in relation to the size of the Dutch population is
exceptionally high, and therefore the average procedural volume
low, it may be argued that the CM-V&O is not ‘too strict’, but that
it exposes the limited accountability of Dutch hospitals in their
current number. Possibly the CM-V&O is even more discrimina-
tive and reliable, and selects more hospitals when tested in a
different, larger healthcare system.
Other studies have proposed similar composite measures using
volume and outcome to assess hospital performances, [17] with
similar results. However, they used the Empirical Bayes method to
adjust outcomes for the procedural volume. The main difference
between our approach and the Empirical Bayes method is that the
Empirical Bayes method uses hospital rankings (from best to worst
performing) instead of rating (better or worse than average), and
therefore also takes into account the uncertainty of the position of
the hospital, based on its performances, in relation to the position
of the other hospitals. To identify outlier hospitals using the
Empirical Bayes method, large procedural volumes are needed.
Therefore, in the Dutch population, using the Empirical Bayes
method, results in a ‘flat line’ with all hospitals performing
‘average’, and fails to identify better performing or under-
performing hospitals. Moreover, a recent study describes that
after the introduction of the DSCA not only national average
outcomes improved, but also differences in hospital performance
were reduced,[11] meaning that the position of one hospital,
relative to another becomes more uncertain. This study proposes a
more simple method, looking only at the position of the hospital in
Table 4. Verification: Outcomes in 2011 of hospitals meeting the different measures in 2010.
Mortality 2010 O/E Mortality 2011 (CI95%) Mortality 2011 (riskadjusted)
Outcome ,2 2010 Yes (82) 0.98 (0.88–1.09) 3.6%
No (7) 1.36 (0.93–1.98) 5.0%
Volume .50 in 2010 Yes (80) 1.01 (0.90–1.12) 3.7%
No (9) 0.89 (0.59–1.35) 3.3%
CM-V&O 2 2010 Yes (21) 0.89 (0.72–1.10) 3.3%
No (68) 1.04 (0.92–1.18) 3.9%
CM-V&O 3 2010 Yes (56) 0.98 (0.80–1.19) 3.6%
No (33) 1.01 (0.89–1.15) 3.7%
Morbidity 2010 O/E Morbidity 2011 (CI95%) Morbidity 2011 (riskadjusted)
Outcome ,1.5 Yes (84) 0.99 (0.95–1.04) 21.3%
No (5) 1.18 (0.99–1.41) 25.5%
Volume .50 Yes (80) 1.00 (0.96–1.05) 21.6%
No (9) 0.94 (0.78–1.14) 20.3%
CM-V&O 1.5* Yes (47) 0.92 (0.89–1.00) 19.8%
No (42) 1.06 (1.01–1.14) 22.8%
CM-V&O 2* Yes (74) 0.97 (0.92–1.02) 20.8%
No (15) 1.16 (1.05–1.28) 25.0%
CM-V&O= combined measure for volume and outcome.
O/E = Observed/Expected outcome ratio.
CI95%= 95% confidence interval around the O/E ratio.
* P,0.05.
doi:10.1371/journal.pone.0088737.t004
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relation to the national average. Therewith, the CM-V&O does
not classify the one hospital as performing better than the other,
but simply classifies a hospital good enough or not good enough.
Although the CM-V&O performed better than the other two
measures in identifying the better performing hospitals and
detecting the underperforming hospitals, we found no significant
difference in mortality in 2011 between hospitals that did and did
not meet the CM-V&O in 2010. As Dishoeck et al. showed in their
study, the ‘rankability’ of hospitals (the part of the heterogeneity
between hospitals that is due to unexplained, hospital dependent
differences) is highly dependent of the number of events in the
different hospitals.[18] For mortality, the rankability is rather low
meaning that most of the differences between hospitals is due to
random variation and may thus be less suitable to rank hospitals.
For morbidity on the other hand, rankability is much better as
there is more systematic variation. This may also explain why the
CM-V&O performed better for morbidity than for mortality. As
mortality is just one aspect of quality, the CM-V&O should
preferably be applied for both mortality and morbidity, or even for
composite quality measures that combine both short and long
term outcome, adverse as well as desirable.[19]
Our study resembles clinical audits or quality registration
programs in other countries, such as the National Surgical Quality
Improvement Program in the United States of America, or the
various nation-wide registries in European countries. Some of
these registrations also use the combination of volume and
outcome to produce annual hospital ratings. However, they
identify positive and negative outliers, but leave the majority of
hospitals unclassified[20,21], arguing that it cannot be proven that
quality of care in these hospitals is insufficient. This line of
reasoning differs from the relationship between providers and
clients across many other areas of society, where the burden of
proof for a good product lies with the provider, instead of the
burden of proof for substandard quality lying with the client. The
analogue in healthcare is that nowadays society will not settle for
the lack of statistical proof that care is substandard, but demands
evidence that the quality of care is adequate, in particular for high-
risk procedures. The CM-V&O that we propose does exactly that.
Policy makers in many countries increasingly respond to societal
concerns about health care safety and quality. In the Netherlands,
societal demand for transparency has been formulated by the
Dutch Health Care Inspectorate as the need for ‘‘justified trust’’.
Hospital volume has been chosen as a proxy for quality, backed up
by enforced volume-based referral in an attempt to improve
outcomes.[3,22]. The present study suggests that CM-V&O is on
both theoretical and practical grounds, better suited than the
volume-measure to provide the ‘‘justified trust’’ in quality of care
that society demands.
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